Browse Category

Company Earnings News 30 November 2025 - 8 December 2025

First Resources Ltd (SGX:EB5): Q3 2025 Profit Surge, ANJ Acquisition and West Papua Exit Reframe the Palm Oil Story

First Resources Ltd (SGX:EB5): Q3 2025 Profit Surge, ANJ Acquisition and West Papua Exit Reframe the Palm Oil Story

Singapore — 8 December 2025 First Resources Ltd, the Singapore‑listed palm oil producer, has moved sharply back onto investors’ radar in late 2025 after a combination of surging quarterly profits, a transformative Indonesian acquisition and the strategic disposal of debt‑laden
Intuitive Surgical (ISRG) Stock on December 7, 2025: Earnings Beat, Da Vinci 5 Momentum and What Wall Street Expects Next

Intuitive Surgical (ISRG) Stock on December 7, 2025: Earnings Beat, Da Vinci 5 Momentum and What Wall Street Expects Next

Intuitive Surgical stock today: where things stand Intuitive Surgical Inc. (NASDAQ: ISRG), the robotics and minimally invasive surgery leader behind the da Vinci and Ion platforms, continues to trade near the top of its 52‑week range as of December 7,
Compass Group PLC (CPG.L) Stock Outlook: 2025 Results Beat, Big Broker Upgrades and What’s Next as of 5 December 2025

Compass Group PLC (CPG.L) Stock Outlook: 2025 Results Beat, Big Broker Upgrades and What’s Next as of 5 December 2025

LONDON, 5 December 2025 – Compass Group PLC’s share price is hovering just above its 52‑week low even after the world’s largest contract caterer delivered another year of double‑digit profit growth and attracted a wave of broker upgrades. That tension
Evolution Mining (ASX: EVN) Share Price on 4 December 2025: Record Profits, Lithium JV and What Analysts Expect Next

Evolution Mining (ASX: EVN) Share Price on 4 December 2025: Record Profits, Lithium JV and What Analysts Expect Next

Evolution Mining Limited (ASX: EVN) heads into 4 December 2025 trading just under all‑time highs, powered by record financial results, surging precious‑metal prices and a new lithium joint venture in Nevada. At Wednesday’s close (3 December), Evolution shares finished at
Exact Sciences (EXAS) Stock: Abbott’s $23 Billion Deal, Q3 Earnings Beat and What Investors Should Watch Now

Exact Sciences (EXAS) Stock: Abbott’s $23 Billion Deal, Q3 Earnings Beat and What Investors Should Watch Now

Exact Sciences Corporation (NASDAQ: EXAS) has turned into one of the most closely watched healthcare stocks heading into December 2025, thanks to a blockbuster takeover agreement with Abbott Laboratories, strong Q3 results, and a rapid share‑price rally that has pushed
1 2 3 4 6
Go toTop